Telephone-Based Disease Management: Why It Does Not Save Money
To generate cost savings, plan sponsors should implement transitional care programs and disease management programs that consider risk, actionability, treatment and program effectiveness, and costs.
Clinical and Financial Outcomes Associated With a Proton Pump Inhibitor Prior-Authorization Program in a Medicaid Population
Plan-Sponsor Savings and Member Experience With Point-of-Service Prescription Step Therapy
The Effect of a Copay Increase on Pharmaceutical Utilization, Expenditures, and Treatment Continuation
